Browse by popular tags
abvd ac220 act acute lymphoblastic leukaemia acute myelogenous leukemia (aml) acute myeloid leukaemia ade admire adoptive cellular therapy alemtuzumab all allogeneic allogeneic stem cell transplant amgen aml aml 17 angioimmunoblastic lymphoma antiviral therapy arctic aspirin autologous stem cell transplant autologous transplant azacitidine b-cell b-cell chronic lymphocytic leukaemia bexarotene blood cancers blood transfusions bone marrow
NHS Logo
The Clinical research facility is part of the NIHR and is funded by the Department of Health
Phase I/II study of the adjunctive use of Nilotinib in patients undergoing reduced intensity allogeneic transplantation for Imatinib resistant or intolerant Chronic Myeloid Leukaemia.
Tasigna in reduced intensity conditioning transplantation evaluation study.